medi-cal no longer covering glp-1 Big News: Medicare & Medicaid Could Soon Cover GLP-1s for Weight Management, A new 5-year federal experiment may finally open access to medications—like Ozempic, Wegovy, Mounjaro, and California's Proposal to Cut GLP-1

BRCA mutations, Lynch syndrome, Li-Fraumeni syndrome, and other hereditary cancer syndromes create environments where additional risk factors deserve careful consideration

Apoptosis 7 , 209215 (2002)

Safety Warning Food supplements must not be used as a substitute for a varied and balanced diet and a healthy lifestyle

During vetting, our Medical Standards and Insights team considers numerous factors, including: company reputation medical credibility marketing claims medications offered overall approach to well-being Because the landscape of GLP-1 medications is constantly evolving, our vetting team monitors these providers on a yearly cadence

Research has demonstrated that specific peptides can influence hormone production, tissue regeneration, and immune system function